Kangmei Pharmaceutical Co.,Ltd. Posted 2.7 Billion Yuan Net Loss in 2022

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 2.7 billion yuan in 2022, reversing a net profit of 7.9 billion yuan for the previous year.

Meanwhile, the company posted 4.2 billion yuan in revenue, up 0.7% year-on-year.

At the end of the reporting period, it had 15.1 billion yuan in total assets and 8.1 billion yuan in total liabilities, with a liability-to-asset ratio of 53.8%.